Mental Disorders Impede Diabetes Care

NOVEMBER 01, 2005

Patients with schizophrenia and major mood disorders have higher rates of type 2 diabetes, compared with patients without mental illness. New research has found, however, that these patients often comprehend less about their disease.

Both disorders affect cognitive function and can impede normal attentiveness, learning, and motivations—essentials in the self-care of type 2 diabetes. The researchers also learned that patients with mental illness and diabetes can improve if they are given specific instructions about diabetes and how to cope. (The findings were reported in Psychosomatics, September 2005.)




SHARE THIS SHARE THIS
0

Become A RESPIMAT T.O.P. Performer 

Get to know RESPIMAT, the slow-moving mist inhaler from Boehringer Ingelheim Pharmaceuticals, Inc.

Watch the RESPIMAT video and test your knowledge with a short multiple-choice quiz. When you get all the answers right, you’ll receive a certificate naming you a RESPIMAT T.O.P. Performer. Why not check it out today?


Pharmacy Times Strategic Alliance
 

Pharmacist Education
Clinical features with downloadable PDFs


Next-Generation Pharmacist® Awards


3rd Annual Convenient Healthcare and Pharmacy Collaborative Conference


SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.